Sermorelin Disclosure, Assumption of Risk & Waiver

Effective Date: January 25, 2026

This Sermorelin Disclosure, Assumption of Risk & Waiver (“Waiver”) applies to all sermorelin-related information, assessments, consultations, recommendations, or services made available through Rejuvimen LLC, including its DBAs Lavena, Lavena Well, and Lavena Wellness (collectively, the “Company,” “we,” “us,” or “our”).

By accessing sermorelin-related content, completing an intake, or proceeding with any sermorelin-related consultation or treatment, you expressly acknowledge, understand, and agree to the following:

1. NON-EMERGENCY TELEHEALTH SERVICES

Sermorelin-related services provided through this platform are non-emergency in nature and may be delivered via telehealth. Telehealth consultations do not include an in-person physical examination and may limit a provider’s ability to identify certain medical conditions.

If you experience chest pain, shortness of breath, fainting, severe dizziness, or any life-threatening symptoms, call 911 immediately.

2. NO PRACTICE OF MEDICINE BY COMPANY

You acknowledge and agree that:

  • The Company does not practice medicine

  • The Company does not diagnose, treat, prescribe, or administer sermorelin

  • The Company does not manufacture, compound, distribute, or dispense medications

  • No doctor-patient relationship is created between you and the Company

All medical decisions are made solely by independent, third-party licensed healthcare providers exercising their own professional judgment.

3. OFF-LABEL & FDA STATUS DISCLOSURE

You understand and acknowledge that:

  • Sermorelin is commonly prescribed off-label

  • Sermorelin is not FDA-approved for anti-aging, wellness, hormone optimization, muscle building, fat loss, or longevity purposes

  • The FDA has not reviewed or approved sermorelin for safety, effectiveness, or quality for these uses

Off-label use is legally permitted but involves inherent uncertainties and risks.

4. LIMITED SCIENTIFIC EVIDENCE

You acknowledge that:

  • Scientific evidence supporting sermorelin therapy may be limited, evolving, conflicting, or preliminary

  • Long-term safety data may be unknown or unavailable

  • Outcomes are unpredictable and vary significantly between individuals

No statements made by the Company constitute a promise, guarantee, or representation of benefit.

5. COMPOUNDED MEDICATION DISCLOSURE (IF APPLICABLE)

If a licensed provider independently prescribes compounded sermorelin, you acknowledge that:

  • Compounded medications are not FDA-approved

  • They have not undergone FDA premarket review

  • Variability in formulation, concentration, and purity may exist

  • Compounding pharmacies are regulated at the state level

6. POTENTIAL RISKS & SIDE EFFECTS

You acknowledge that sermorelin therapy may involve known and unknown risks, including but not limited to:

  • Injection-site reactions (pain, swelling, redness)

  • Headache, dizziness, nausea, or flushing

  • Fatigue or sleep disturbances

  • Changes in blood sugar or insulin sensitivity

  • Hormonal or metabolic effects

  • Worsening of existing medical conditions

  • Serious injury or other unanticipated adverse events

7. ASSUMPTION OF RISK

You knowingly, voluntarily, and irrevocably assume all risks, whether known or unknown, foreseeable or unforeseeable, associated with sermorelin therapy, including risks related to:

  • Off-label use

  • Compounded formulations

  • Telehealth-based evaluation

  • Limited or emerging scientific evidence

8. NO GUARANTEES OR WARRANTIES

You expressly acknowledge and agree that:

  • No results are guaranteed

  • Lack of benefit or adverse outcomes may occur

  • Any references to potential benefits are not guarantees

9. USER RESPONSIBILITIES

You agree to:

  • Provide complete and accurate medical information

  • Disclose all medications, supplements, and health conditions

  • Follow provider instructions exactly

  • Seek in-person or emergency care when appropriate

10. RELEASE OF LIABILITY & WAIVER OF CLAIMS

To the maximum extent permitted by law, you irrevocably release, waive, discharge, and hold harmless the Company from any and all claims, damages, or causes of action arising from or related to:

  • Sermorelin therapy or lack of results

  • Off-label or compounded use

  • Provider clinical decisions

  • Adverse reactions or complications

This waiver includes claims based on negligence, to the fullest extent allowed by law.

11. INDEMNIFICATION

You agree to indemnify and defend the Company against any claims, losses, damages, or expenses (including attorneys’ fees) arising from:

  • Your use or misuse of sermorelin

  • Failure to follow medical guidance

  • Inaccurate or incomplete information you provide

12. ACKNOWLEDGMENT & BINDING CONSENT

By proceeding, you affirm that:

  • You have read and fully understand this Waiver

  • You understand you are giving up legal rights

  • You voluntarily agree to all terms

Sermorelin Disclosure, Assumption of Risk & Waiver

Effective Date: January 25, 2026

This Sermorelin Disclosure, Assumption of Risk & Waiver (“Waiver”) applies to all sermorelin-related information, assessments, consultations, recommendations, or services made available through Rejuvimen LLC, including its DBAs Lavena, Lavena Well, and Lavena Wellness (collectively, the “Company,” “we,” “us,” or “our”).

By accessing sermorelin-related content, completing an intake, or proceeding with any sermorelin-related consultation or treatment, you expressly acknowledge, understand, and agree to the following:

1. NON-EMERGENCY TELEHEALTH SERVICES

Sermorelin-related services provided through this platform are non-emergency in nature and may be delivered via telehealth. Telehealth consultations do not include an in-person physical examination and may limit a provider’s ability to identify certain medical conditions.

If you experience chest pain, shortness of breath, fainting, severe dizziness, or any life-threatening symptoms, call 911 immediately.

2. NO PRACTICE OF MEDICINE BY COMPANY

You acknowledge and agree that:

  • The Company does not practice medicine

  • The Company does not diagnose, treat, prescribe, or administer sermorelin

  • The Company does not manufacture, compound, distribute, or dispense medications

  • No doctor-patient relationship is created between you and the Company

All medical decisions are made solely by independent, third-party licensed healthcare providers exercising their own professional judgment.

3. OFF-LABEL & FDA STATUS DISCLOSURE

You understand and acknowledge that:

  • Sermorelin is commonly prescribed off-label

  • Sermorelin is not FDA-approved for anti-aging, wellness, hormone optimization, muscle building, fat loss, or longevity purposes

  • The FDA has not reviewed or approved sermorelin for safety, effectiveness, or quality for these uses

Off-label use is legally permitted but involves inherent uncertainties and risks.

4. LIMITED SCIENTIFIC EVIDENCE

You acknowledge that:

  • Scientific evidence supporting sermorelin therapy may be limited, evolving, conflicting, or preliminary

  • Long-term safety data may be unknown or unavailable

  • Outcomes are unpredictable and vary significantly between individuals

No statements made by the Company constitute a promise, guarantee, or representation of benefit.

5. COMPOUNDED MEDICATION DISCLOSURE (IF APPLICABLE)

If a licensed provider independently prescribes compounded sermorelin, you acknowledge that:

  • Compounded medications are not FDA-approved

  • They have not undergone FDA premarket review

  • Variability in formulation, concentration, and purity may exist

  • Compounding pharmacies are regulated at the state level

6. POTENTIAL RISKS & SIDE EFFECTS

You acknowledge that sermorelin therapy may involve known and unknown risks, including but not limited to:

  • Injection-site reactions (pain, swelling, redness)

  • Headache, dizziness, nausea, or flushing

  • Fatigue or sleep disturbances

  • Changes in blood sugar or insulin sensitivity

  • Hormonal or metabolic effects

  • Worsening of existing medical conditions

  • Serious injury or other unanticipated adverse events

7. ASSUMPTION OF RISK

You knowingly, voluntarily, and irrevocably assume all risks, whether known or unknown, foreseeable or unforeseeable, associated with sermorelin therapy, including risks related to:

  • Off-label use

  • Compounded formulations

  • Telehealth-based evaluation

  • Limited or emerging scientific evidence

8. NO GUARANTEES OR WARRANTIES

You expressly acknowledge and agree that:

  • No results are guaranteed

  • Lack of benefit or adverse outcomes may occur

  • Any references to potential benefits are not guarantees

9. USER RESPONSIBILITIES

You agree to:

  • Provide complete and accurate medical information

  • Disclose all medications, supplements, and health conditions

  • Follow provider instructions exactly

  • Seek in-person or emergency care when appropriate

10. RELEASE OF LIABILITY & WAIVER OF CLAIMS

To the maximum extent permitted by law, you irrevocably release, waive, discharge, and hold harmless the Company from any and all claims, damages, or causes of action arising from or related to:

  • Sermorelin therapy or lack of results

  • Off-label or compounded use

  • Provider clinical decisions

  • Adverse reactions or complications

This waiver includes claims based on negligence, to the fullest extent allowed by law.

11. INDEMNIFICATION

You agree to indemnify and defend the Company against any claims, losses, damages, or expenses (including attorneys’ fees) arising from:

  • Your use or misuse of sermorelin

  • Failure to follow medical guidance

  • Inaccurate or incomplete information you provide

12. ACKNOWLEDGMENT & BINDING CONSENT

By proceeding, you affirm that:

  • You have read and fully understand this Waiver

  • You understand you are giving up legal rights

  • You voluntarily agree to all terms